70 related articles for article (PubMed ID: 20020777)
1. Evaluation of established coronary heart disease on the basis of HDL and non-HDL NMR lipid profiling.
Kostara CE; Papathanasiou A; Cung MT; Elisaf MS; Goudevenos J; Bairaktari ET
J Proteome Res; 2010 Feb; 9(2):897-911. PubMed ID: 20020777
[TBL] [Abstract][Full Text] [Related]
2. NMR-based lipidomic analysis of blood lipoproteins differentiates the progression of coronary heart disease.
Kostara CE; Papathanasiou A; Psychogios N; Cung MT; Elisaf MS; Goudevenos J; Bairaktari ET
J Proteome Res; 2014 May; 13(5):2585-98. PubMed ID: 24689886
[TBL] [Abstract][Full Text] [Related]
3. To what extent are the effects of diet on coronary heart disease lipid-mediated?
Serrano-Martinez M; Martinez-Losa E; Prado-Santamaria M; Brugarolas-Brufau C; Fernandez-Jarne E; Martinez-Gonzalez MA
Int J Cardiol; 2004 May; 95(1):35-8. PubMed ID: 15159035
[TBL] [Abstract][Full Text] [Related]
4. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
5. Extent to which accepted serum lipid goals are achieved in a contemporary general medical population with coronary heart disease risk equivalents.
Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
Am J Cardiol; 2006 Nov; 98(9):1231-3. PubMed ID: 17056335
[TBL] [Abstract][Full Text] [Related]
6. [Fatty acid makeup of different lipid fractions of plasma lipoproteins in persons dying suddenly from coronary heart disease].
Aptekar' SG
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):36-42. PubMed ID: 7259866
[TBL] [Abstract][Full Text] [Related]
7. [Dyslipidemic patients with coronary cardiopathy. Effect of different doses of OMEGA-3 fatty acids on serum lipids and lipoproteins].
Arteaga A; Villanueva CL; Skorin C; Guasch V; Solís de Ovando F; Velasco N; Acosta AM; Leighton F
Rev Med Chil; 1993 Jun; 121(6):618-25. PubMed ID: 8278696
[TBL] [Abstract][Full Text] [Related]
8. Effect of eicosapentaenoic/docosahexaenoic fatty acids and soluble fibers on blood lipids of individuals classified into different levels of lipidemia.
Castro IA; Monteiro VC; Barroso LP; Bertolami MC
Nutrition; 2007 Feb; 23(2):127-37. PubMed ID: 17234506
[TBL] [Abstract][Full Text] [Related]
9. [Microalbuminuria, lipid changes and coronary heart disease in non-insulin-dependent diabetics].
Durruty P; Díaz J; Zanetti L; de la Varas MA; García de los Ríos M
Rev Med Chil; 1998 Dec; 126(12):1425-33. PubMed ID: 10349156
[TBL] [Abstract][Full Text] [Related]
10. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
Shai I; Rimm EB; Hankinson SE; Curhan G; Manson JE; Rifai N; Stampfer MJ; Ma J
Circulation; 2004 Nov; 110(18):2824-30. PubMed ID: 15492318
[TBL] [Abstract][Full Text] [Related]
11. Consumption of trans fats and estimated effects on coronary heart disease in Iran.
Mozaffarian D; Abdollahi M; Campos H; Houshiarrad A; Willett WC
Eur J Clin Nutr; 2007 Aug; 61(8):1004-10. PubMed ID: 17268422
[TBL] [Abstract][Full Text] [Related]
12. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.
Onat A
Anadolu Kardiyol Derg; 2004 Sep; 4(3):236-45. PubMed ID: 15355827
[TBL] [Abstract][Full Text] [Related]
13. Erythrocyte membrane, plasma and atherosclerotic plaque lipid pattern in coronary heart disease.
Lausada NR; Boullón S; Boullón F; Tacconi de Gómez Dumm IN
Medicina (B Aires); 2007; 67(5):451-7. PubMed ID: 18051228
[TBL] [Abstract][Full Text] [Related]
14. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[TBL] [Abstract][Full Text] [Related]
15. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
16. Diet and coronary heart disease.
Oliver MF
Hum Nutr Clin Nutr; 1982; 36(6):413-27. PubMed ID: 6298152
[TBL] [Abstract][Full Text] [Related]
17. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
Gotto AM
Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment.
Ansell BJ; Navab M; Hama S; Kamranpour N; Fonarow G; Hough G; Rahmani S; Mottahedeh R; Dave R; Reddy ST; Fogelman AM
Circulation; 2003 Dec; 108(22):2751-6. PubMed ID: 14638544
[TBL] [Abstract][Full Text] [Related]
19. Distribution of lipid phenotypes in community-living men with coronary heart disease. High prevalence of isolated low levels of high-density lipoprotein cholesterol.
Rubins HB; Schectman G; Wilt TJ; Iwane MK
Arch Intern Med; 1992 Dec; 152(12):2412-6. PubMed ID: 1456850
[TBL] [Abstract][Full Text] [Related]
20. [Significance of lipids in the diagnosis of coronary heart disease in patient groups and individuals].
Kladetzky RG; Santosa H; Schulte H; Spiller P
Z Kardiol; 1986 Apr; 75(4):220-4. PubMed ID: 3727662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
